Their study detected an inverse association between HJURP expression and CRC prognosis, determined that silencing of HJURP inhibited the proliferation, migration, invasion, and tumorigenicity of CRC cells, and suggested that HJURP might be a potential prognostic biomarker and a new target for drug discovery in CRC (Kang et al., 2020). The gene discussed is HJURP; the disease is colorectal carcinoma.